{'fraction_non_alphanumeric': 0.04946236559139785, 'fraction_numerical': 0.035483870967741936, 'mean_word_length': 4.929936305732484, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Site of anti-nociceptive action of a new benzomorphan derivative ID-1229.

The site of anti-nociceptive action of a new benzomorphan derivative ID-1229, 2-[3-(p-fluorobenzoyl)-1-propyl]-5 alpha, 9 alpha-dimethyl-2'-hydroxyl-6, 7-benzomorphan was investigated using electrophysiological methods. In rabbits, ID-1229 (0.1-0.5 mg/kg) caused slowing in the EEG, and depressed the evoked potentials recorded from the sensory cortex and the Nucleus ventralis posterolateralis of the thalamus elicited by sciatic stimulation. A small dose (1 mg/kg) of ID-1229 decreased the bradykinin-induced unitary discharges of lamina V neuron of the spinal dorsal horn in intact rabbits but not in spinal rabbits. These results suggest that ID-1229 inhibits the sensory transmission of bradykinin-induced pain at the dorsal horn of the spinal cord, through its facilitatory action on the descending inhibitory system from the supra-spinal structure.